Publicaciones en colaboración con investigadoras/es de Novartis (Sweden) (20)

2012

  1. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: Their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice

    Neurobiology of Aging, Vol. 33, Núm. 11, pp. 2641-2660

  2. Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology

    Journal of Neuroscience, Vol. 32, Núm. 4, pp. 1273-1283

2010

  1. Effect of nateglinide on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

  2. Effect of valsartan on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

2009

  1. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances

    Neurobiology of Aging, Vol. 30, Núm. 12, pp. 1936-1948

2007

  1. Occurrence and co-localization of amyloid β-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice

    Neurobiology of Aging, Vol. 28, Núm. 8, pp. 1221-1230

2006

  1. Immunocytochemical localization of metabotrophic (mGluR2/3 and mGluR4a) and ionotropic (GluR2/3) glutamate receptors in adrenal medullary ganglion cells

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 141-147

  2. Selective vulnerability of different types of commissural neurons for amyloid β-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology

    Brain, Vol. 129, Núm. 11, pp. 2992-3005

2005

  1. Immunoreactivity for the group III receptor subtype mGluR4a in the visual layers of the rat superior colliculus

    Neuroscience, Vol. 131, Núm. 3, pp. 627-633

2002

  1. Dietary fatty acid composition affects aminopeptidase activities in the testes of mice

    International Journal of Andrology, Vol. 25, Núm. 2, pp. 113-118

2001

  1. Immunoreactivity for the group III metabotropic glutamate receptor subtype mGluR4a in the superficial laminae of the rat spinal dorsal horn

    Journal of Comparative Neurology, Vol. 430, Núm. 4, pp. 448-457

2000

  1. Immunocytochemical localization of the metabotropic glutamate receptor mGluR4a in the piriform cortex of the rat

    Journal of Comparative Neurology, Vol. 417, Núm. 3, pp. 263-274

  2. Immunolocalization of the mGluR1b splice variant of the metabotropic glutamate receptor 1 at parallel fiber-Purkinje cell synapses in the rat cerebellar cortex

    Journal of Neurochemistry, Vol. 74, Núm. 3, pp. 1301-1309

1999

  1. Clustering of the group III metabotropic glutamate receptor 4a at parallel fiber synaptic terminals in the rat cerebellar molecular layer

    Neuroscience Research, Vol. 35, Núm. 1, pp. 71-74

  2. Developmental expression of the group III metabotropic glutamate receptor mGluR4a in the medial nucleus of the trapezoid body of the rat

    Journal of Comparative Neurology, Vol. 411, Núm. 3, pp. 431-440

  3. Distribution of the group II metabotropic glutamate receptors (mGluR2/3) in the enteric nervous system of the rat

    Neuroscience Letters, Vol. 276, Núm. 2, pp. 91-94

1998

  1. Immunocytochemical localization of the mGluR1b metabotropic glutamate receptor in the rat hypothalamus

    Journal of Comparative Neurology, Vol. 390, Núm. 2, pp. 225-233

  2. Immunohistochemical localization of the mGluR1β metabotropic glutamate receptor in the adult rodent forebrain: Evidence for a differential distribution of mGluR1 splice variants

    Journal of Comparative Neurology, Vol. 400, Núm. 3, pp. 391-407

  3. Localization of the mGlu4a metabotropic glutamate receptor in rat cerebellar cortex

    Histochemistry and Cell Biology, Vol. 109, Núm. 2, pp. 135-139

  4. The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A: Implications for drug-drug interactions and pharmacological activity of the main metabolite

    Drug Metabolism and Disposition, Vol. 26, Núm. 8, pp. 802-811